Literature DB >> 8055651

Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.

K R Kaderlik1, G J Mulder, R J Turesky, N P Lang, C H Teitel, M P Chiarelli, F F Kadlubar.   

Abstract

The food-borne carcinogenic anpan>d mutagenic pan> class="Disease">heterocyclic aromatic amines undergo bioactivation to the corresponding N-hydroxy (OH)-arylamines and the subsequent N-glucuronidation of these metabolites is regarded as an important detoxification reaction. In this study, the rates of glucuronidation for the N-OH derivatives of 2-amino-3-methylimidazo[4,5-f]-quinoline (IQ), 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP), 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) by liver microsomal glucuronosyltransferase were compared to that of the proximate human urinary bladder carcinogen, N-OH-aminobiphenyl (N-OH-ABP) and the proximate rat colon carcinogen N-OH-3,2'-dimethyl-4-amino-biphenyl (N-OH-DMABP). Human liver microsomes catalyzed the uridine 5'-diphosphoglucuronic acid (UDPGA)-dependent glucuroidation of N-OH-IQ, N-OH-PhIP, N-OH-Glu-P-1 and N-OH-MeIQx at rates of 59%, 42%, 35% and 27%, respectively, of that measured for N-OH-ABP (11.5 nmol/min/mg). Rat liver microsomes also catalyzed the UDPGA-dependent glucuronidation of N-OH-PhIP, N-OH-Glu-P-1 and N-OH-IQ at rates of 30%, 20% and 10%, respectively of that measured for N-OH-DMABP (11.2 nmol/min/mg); activity towards N-OH-MeIQx was not detected. Two glucuronide(s) of N-OH-PhIP, designated I and II, were separated by HPLC. Conjugate II was found to be chromatographically and spectrally identical with a previously reported major biliary metabolite of PhIP in the rat, while conjugate I was identical with a major urinary metabolite of PhIP in the dog. Hepatic microsomes from rat, dog and human were found to catalyze the formation of both conjugates. The rat preferentially formed conjugate II (I to II ratio of 1:15), while the dog and human formed higher relative amounts of conjugate I (I to II ratio of 2.5:1.0 and 1.3:1.0 respectively). Fast atom bombardment mass spectrometry of conjugates I and II gave the corresponding molecular ions and showed nearly identical primary spectra. However, collision-induced spectra were distinct and were consistent with the identity of conjugates I and II as structural isomers. Moreover, the UV spectrum of conjugate I exhibited a lambda max at 317 nm and was essentially identical to that of N-OH-PhIP, while conjugate II was markedly different with a lambda max of 331 nm. Both conjugates were stable in 0.1 N HCl and were resistant to hydrolysis by rat, dog and human liver microsomal beta-glucuronidases.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055651     DOI: 10.1093/carcin/15.8.1695

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation.

Authors:  A Galijatovic; Y Otake; U K Walle; T Walle
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  1H nuclear magnetic resonance spectroscopy-based studies of the metabolism of food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline by human intestinal microbiota.

Authors:  Christèle Humblot; Bruno Combourieu; Marja-Liisa Väisänen; Jean-Pierre Furet; Anne-Marie Delort; Sylvie Rabot
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

3.  A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.

Authors:  Chi Chen; Xiaochao Ma; Michael A Malfatti; Kristopher W Krausz; Shioko Kimura; James S Felton; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2007-02-06       Impact factor: 3.739

Review 4.  Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.

Authors:  Rachel N Carmody; Peter J Turnbaugh
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

5.  Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone).

Authors:  Chi Chen; Linghua Meng; Xiaochao Ma; Kristopher W Krausz; Yves Pommier; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2006-06-14       Impact factor: 4.030

Review 6.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

7.  Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.

Authors:  Ming Yin; Zhibin Hu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

Review 8.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors:  Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal:  Nat Rev Microbiol       Date:  2016-03-14       Impact factor: 60.633

9.  Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ] quinoline in mice.

Authors:  Jun-Hua Yuan; Yan-Qing Li; Xiao-Yun Yang
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

10.  Bioactivation of Heterocyclic Aromatic Amines by UDP Glucuronosyltransferases.

Authors:  Tingting Cai; Lihua Yao; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2016-04-18       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.